SEC Form 4 · accession 0001104659-17-061153
Cardiff Oncology, Inc. · CRDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary S Jacob
Director
Period of report
Oct 4, 2017
Accepted (ET)
Oct 5, 2017 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001213037
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.72 | Oct 4, 2017 | A | 38,106 | A | Oct 4, 2018 | Oct 4, 2027 | Common Stock | 38,106 | 193,779 | D |